For the period under review , Group revenue has been increased by 12.72% (or RM3.18 million) from RM 24.98 million to RM 28.15 million due to increasing sales from existing customers of subsidiaries. The profit after tax increased by 9.34 % ( or RM 0.35 million) from RM 3.75 million due to contribution from unrealised gain on foreign exchange. The Supercomal Medical Products (SMP) contributed 87% of the group profit.